Oncological impact of neoadjuvant hormonal therapy on permanent iodine‐125 seed brachytherapy in patients with low‐ and intermediate‐risk prostate cancer
Atsushi Takamoto(Okayama University), Yasutomo Nasu(Okayama University), Motoo Araki(Okayama University), Takuya Sadahira(Okayama University), Kensuke Bekku(Okayama University), Norihisa Katayama(Okayama University), Hiroyuki Yanai(Okayama University Hospital), Ryuta Tanimoto(Okayama University), Shin Ebara(Okayama University), Koichiro Wada(Shimane University)
Cited by 3
Related Papers
Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression Profiles
|Cancer Research|2007|206
Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy
|Molecular and Clinical Oncology|2016|79
Analysis of Factors Associated With Radiation-Induced Bronchiolitis Obliterans Organizing Pneumonia Syndrome After Breast-Conserving Therapy
|International Journal of Radiation Oncology*Biology*Physics|2008|69
REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer
|International Journal of Molecular Medicine|2007|63
Comparison of the Protective Effect of N-Acetylcysteine by Different Treatments on Rat Myocardial Ischemia-Reperfusion Injury
|Journal of Pharmacological Sciences|2008|55